Cardiology
Cardiology
Advertisement
CardioNerdsCardioNerds | December 18, 2024
The CardioNerds and colleagues review the differential diagnosis for peripartum cardiomyopathy.
Listen Now
Rob DillardAHA 2024: CardioNerds | December 13, 2024
A study shows how how advancements in diagnostic tools and treatments for ATTR-CM have improved risk profiles.
Rob DillardAHA 2024: CardioNerds | December 13, 2024
A recent post-hoc analysis of the ATTRibute-CM trial shows the potential for acoramidis in treating ATTR-CM.
Rob DillardAHA 2024 | December 13, 2024
A study found an overall decline in surgical myectomy with ICD procedures since 2016.
Laura LitwinHypertension | December 12, 2024
Older adults diagnosed with hypertension can alleviate lung function impairments and mechanics with an active lifestyle.
Laura LitwinAtrial Fibrillation | December 12, 2024
A recent study evaluated the association between resting heart rate and incident atrial fibrillation in Black patients.
Jordana JampelPreventive Cardiology | December 12, 2024
Exposures included missense variants in TRR associated with increasing transthyretin tetramer destabilization.
Jordana JampelPreventive Cardiology | December 6, 2024
Pulsatility index and transfer function gain were calculated.
Jordana JampelAtherosclerotic Disease | December 4, 2024
Researchers explored how immune checkpoint inhibitors interact with immune cells in arterial plaques.
Rob DillardAHA 2024 | December 3, 2024
A new study shows that progression from low burden atrial fibrillation (AF) is associated with negative outcomes.
Rob DillardAHA 2024 | December 3, 2024
Individuals with cardiac implantable electronic devices have a higher risk of tricuspid regurgitation.
CardioNerdsCardioNerds | December 2, 2024
The CardioNerds discuss a case involving a patient who presented with stress cardiomyopathy leading to cardiogenic shock.
Rob DillardAHA 2024: CardioNerds | November 27, 2024
The U.S. FDA recently approved Attruby (acoramidis) for adults with ATTR-CM to reduce cardiovascular death, hospitalization.
Jordana JampelStroke | November 26, 2024
The rise in these regions is despite the overall global decline in incidences.
Amit Goyal, MDAHA 2024: CardioNerds | November 26, 2024
A study highlights the significant HCRU and costs associated with ATTR-CM.
Amit Goyal, MDAHA 2024: CardioNerds | November 26, 2024
Promising long-term outcomes from the ongoing OLE of the ATTRibute-CM trial highlight the efficacy of acoramidis.
Rob DillardAHA 2024: CardioNerds | November 26, 2024
A case study highlights the importance of avoiding anchoring bias in the diagnosis of cardiac amyloidosis.
Rob DillardAHA 2024: CardioNerds | November 26, 2024
The diagnosis of AL amyloidosis requires a high index of suspicion to render a prompt diagnosis and appropriate treatment.
Rob DillardAHA 2024 | November 25, 2024
Mortality rates among inpatients with HF who undergo AF catheter ablation are relatively low.
Rob DillardAHA 2024 | November 25, 2024
BC survivors undergoing CIED placement have a higher risk of periprocedural complications.
Advertisement
Advertisement
Advertisement
Latest News

December 24, 2024